Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02052557 · ClinicalTrials.gov registry record · Phase 4
The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery
A Phase 4 study, sponsored by Des Moines University.
- Completed
- Registry status
- Phase 4
- Development phase
- 51
- Enrollment target
NCT02052557: Completed Phase 4 study, sponsored by Des Moines University.
NCT02052557 is a Phase 4 study that has completed, run by Des Moines University. The registered enrollment target is 51 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02052557, a Phase 4 study, has completed, sponsored by Des Moines University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effect of Exparel on pain control and patient outcome after colon resection. The investigators will evaluate the clinical course of the patients who receive exparel as compared to the patients who do not receive exparel. Exparel is a 72 hour bupivacaine which is slowly released from lysosomes over the course of three days. A long acting local anesthetic should provide better pain control than conventional bupivacaine which has a 3.5 hour half-life.
Primary Outcome
Will measure the amount of PCA use for the first 48 hours after surgery.
Interventions
- DRUG Bupivacaine
- DRUG Bupivacaine liposome suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
What the finished NCT02052557 record still lists
NCT02052557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT02052557 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02052557 about?
NCT02052557 is a clinical study titled "The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery". The purpose of the study is to evaluate the effect of Exparel on pain control and patient outcome after colon resection. The investigators will evaluate the clinical course of the patients who receive exparel as compared to the patients who do not receive exparel. Exparel is a 72 hour bupivacaine wh...
What is the current status of trial NCT02052557?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 51 participants. The study started on 2013-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT02052557?
The interventions under investigation include: Bupivacaine (DRUG), Bupivacaine liposome suspension (DRUG).
Who is sponsoring clinical trial NCT02052557?
This trial is sponsored by Des Moines University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02052557's enrollment target sits among peer trials
51 1249th of 2000 higher than 746 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia